Home » Clinical Trials » DefINe: A trial to test the use of deferiprone in people with neuroferritinopathy

Research area:

Rare disease

Disease:

Neuroferritinopathy

Intervention:

Therapeutics – small molecules

Phase:

Phase II

DefINe: A trial to test the use of deferiprone in people with neuroferritinopathy

Intervention

Therapeutics – small molecules

Funding awarded to

University of Cambridge

Public registration details (where available)

ISRCTN15571700

Planned trial start and expected end date

April 2023 to February 2026

Related news

Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

Read more: Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

Read more: MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

UK Drug Discovery Consortium symposium

Read more: UK Drug Discovery Consortium symposium